Increased SOX9 expression drives prostate cancer (PCa) tumor growth and angiogenesis and promotes prostate cancer invasion by reactivating the WNT/β-catenin signaling that mediates ductal morphogenesis in fetal prostate [8]. This evidence concerns the gene SOX9 and prostate cancer.